findmyKOL
Clinical trialNCT00003327UnknownPhase 2Interventional

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

SponsorTheradexEnrollment60Head and Neck Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Arlene A. Forastiere, MD

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • California Cancer Center

    Fresno, California, United States

  • Loma Linda University Medical Center

    Loma Linda, California, United States

  • Memorial Regional Cancer Center at Memorial Regional Hospital

    Hollywood, Florida, United States

  • Sylvester Cancer Center, University of Miami

    Miami, Florida, United States

  • Savannah Hematology Oncology Associates

    Savannah, Georgia, United States

  • Decatur Memorial Hospital Cancer Care Institute

    Decatur, Illinois, United States

  • Mary Bird Perkins Cancer Center

    Baton Rouge, Louisiana, United States

  • Maine Center for Cancer Medicine and Blood Disorders

    Scarborough, Maine, United States

  • Johns Hopkins Oncology Center

    Baltimore, Maryland, United States

  • Kansas City Internal Medicine

    Kansas City, Missouri, United States

  • Lourdes Regional Cancer Center

    Binghamton, New York, United States

  • Saint Vincent Catholic Medical Center of New York

    New York, New York, United States

  • Presbyterian Healthcare

    Charlotte, North Carolina, United States

  • Akron City Hospital

    Akron, Ohio, United States

  • Medical Oncology Hematology Associates, Inc.

    Dayton, Ohio, United States

  • Reading Hospital and Medical Center

    Reading, Pennsylvania, United States

  • Joe Arrington Cancer Research and Treatment Center

    Lubbock, Texas, United States

  • Cancer Care Institute of South Texas

    San Antonio, Texas, United States

  • Danville Hematology and Oncology, Inc.

    Danville, Virginia, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 1997
Primary completion
Completion
Last update posted
24 Jul 2008
Registered enrollment
60
Registry id
NCT00003327

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.